MeSH Browser

MeSH Heading: Moxalactam
Tree Number(s): D02.065.589.099.625; D02.886.520.575; D03.633.100.300.625
Unique ID: D009070
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D009070
Scope Note: Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.
Entry Term(s): 1-Oxacephalosporin; 6059-S; Disodium Latamoxef; Disodium Moxalactam; Festamoxin; Lamoxactam; Latamoxef; Lilly 127935; Ly-127935; Ly127935; Moxalactam Disodium; S-6059; Shiomarin
Pharm Action: Anti-Bacterial Agents
Registry Number: VUF6C936Z3
Related Numbers: 5APW73W3QZ; 64952-97-2
CAS Type 1 Name: 5-Oxa-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-
NLM Classification #: QV 350
Previous Indexing: Antibiotics (1966-1980); Cefamandole/analogs & derivatives (1978-1983); Cephalosporins (1966-1974); Cephamycins (1975-1977); Lactams (1972-1980)
Public MeSH Note: 84
History Note: 84
Date Established: 1984/01/01
Date of Entry: 1983/04/04
Revision Date: 2016/05/31

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0014142
Registry Number: VUF6C936Z3
Related Numbers: 5APW73W3QZ; 64952-97-2
Scope Note: Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.
Terms: Moxalactam Preferred Term
Term UI T027077
Date01/01/1999
LexicalTag NON
ThesaurusID; Lamoxactam
Term UI T027075
Date04/04/1983
LexicalTag NON
ThesaurusID UNK (19XX); Latamoxef
Term UI T027076
Date04/04/1983
LexicalTag NON
ThesaurusID

Moxalactam MeSH Descriptor Data 2023